| 标题 |
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of The American Academy of Dermatology 作者:Andrew Blauvelt; Jonathan I. Silverberg; Charles Lynde; Thomas Bieber; Samantha Eisman; et al 出版日期:2021-08-17 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)